UK markets close in 8 hours 5 minutes

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
103.79-0.07 (-0.07%)
At close: 04:00PM EDT
103.51 -0.28 (-0.27%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 39.74B
Enterprise value 32.38B
Trailing P/E 7.06
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.87
Price/book (mrq)2.87
Enterprise value/revenue 4.79
Enterprise value/EBITDA -9.86

Trading information

Stock price history

Beta (5Y monthly) 1.59
52-week change 3-27.33%
S&P500 52-week change 321.59%
52-week high 3144.43
52-week low 362.55
50-day moving average 3100.11
200-day moving average 399.28

Share statistics

Avg vol (3-month) 33.83M
Avg vol (10-day) 33.5M
Shares outstanding 5382.88M
Implied shares outstanding 6382.88M
Float 8344.87M
% held by insiders 19.62%
% held by institutions 173.18%
Shares short (28 Mar 2024) 421.44M
Short ratio (28 Mar 2024) 45.26
Short % of float (28 Mar 2024) 47.38%
Short % of shares outstanding (28 Mar 2024) 45.60%
Shares short (prior month 29 Feb 2024) 422.11M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin -68.84%
Operating margin (ttm)0.21%

Management effectiveness

Return on assets (ttm)-11.96%
Return on equity (ttm)-28.59%

Income statement

Revenue (ttm)6.85B
Revenue per share (ttm)17.93
Quarterly revenue growth (yoy)-44.70%
Gross profit (ttm)N/A
Net income avi to common (ttm)-4.71B
Diluted EPS (ttm)-12.33
Quarterly earnings growth (yoy)-85.20%

Balance sheet

Total cash (mrq)8.6B
Total cash per share (mrq)22.52
Total debt (mrq)1.24B
Total debt/equity (mrq)8.97%
Current ratio (mrq)3.42
Book value per share (mrq)36.27

Cash flow statement

Operating cash flow (ttm)-3.12B
Levered free cash flow (ttm)-2.38B